Yale SPORE in Lung Cancer Career Enhancement Program
耶鲁 SPORE 肺癌职业提升计划
基本信息
- 批准号:10203858
- 负责人:
- 金额:$ 7.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-26 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAppointmentAreaAwardBasic ScienceBiochemistryBiologicalBiophysicsCancer BiologyCollaborationsColon CarcinomaCommunitiesDevelopmentDiagnosisDisciplineFacultyFellowship ProgramFosteringFoundationsFundingGenerationsGeneticGoalsGrowthHumanInfrastructureInstitutionMalignant neoplasm of lungMalignant neoplasm of prostateMalignant neoplasm of thoraxMedicalMedical OncologyMedical ResearchMentorsMinority RecruitmentMolecularPathologyPatientsPharmacologyPhysiciansPreventionProceduresProcessPulmonologyResearchResearch PersonnelScienceScientistSeedsSolidTalentsTrainingTranslational ResearchUnited States National Institutes of HealthWorkYale Cancer Centeranticancer researchbasecareerclinical centerclinical investigationdesigninterestknowledge basemalignant breast neoplasmmedical schoolsnext generationnovelpersonalized medicineprogramsrecruittranslational impacttranslational research programtranslational scientist
项目摘要
PROGRAM SUMMARY
The number of physician-scientists working in lung cancer has not kept pace with the overall growth of the
medical research community or with the growth in our basic knowledge base, resulting in an increasing number
of unrealized basic and translational research opportunities. Yale is uniquely suited to helping rebuild this base
with our strong commitment to translational research. The Career Enhancement Program (CEP) of the Yale
SPORE in Lung Cancer (YSILC) has been designed to contribute substantively to ongoing efforts and new
initiatives attempting to address this problem. The goal of the CEP is to educate a new generation of
investigators committed to translational research in lung cancer. The CEP has substantial institutional
commitment, both in terms of funding and infrastructure. For example, our translational research office at Yale
(also led by Dr. Herbst, YSILC PI) has been committed to providing early seed funding and translational
support to young investigators early in their research careers. Potential CEP candidates include promising
junior faculty who are interested in establishing their careers in translational lung cancer research and/or
established investigators whose previous research has been in other areas and would like to transition into
lung cancer focused research. Junior faculty awardees will be paired with mentors who are more established
lung cancer investigators with a documented record of successful mentoring. In this way, the YSILC will
stimulate the development of the next generation of physician scientists, addressing the most challenging
issues in lung cancer research.
程序摘要
从事肺癌的医师科学家的数量并未与
医学研究界或我们的基本知识基础的增长,导致数量越来越多
未实现的基本和转化研究机会。耶鲁大学非常适合帮助重建这个基础
我们对翻译研究的坚定承诺。耶鲁大学的职业增强计划(CEP)
肺癌中的孢子(YSILC)旨在为持续的努力和新的孢子做出实质性贡献
试图解决这个问题的计划。 CEP的目标是教育新一代
致力于肺癌转化研究的研究人员。 CEP具有实质性的机构
在资金和基础设施方面的承诺。例如,我们在耶鲁大学的翻译研究办公室
(也由YSILC PI Herbst博士领导)已致力于提供早期的种子资金和翻译
在研究生涯的早期对年轻研究人员的支持。潜在的CEP候选人包括有希望的
有兴趣在转化肺癌研究和/或
建立的调查人员以前的研究已经在其他领域,并希望过渡到
以肺癌为本的研究。初级教师获奖者将与更加成熟的导师配对
肺癌调查员有记录的成功指导记录。这样,YSILC将会
刺激下一代医师科学家的发展,解决最具挑战性的
肺癌研究中的问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Harriet M. Kluger其他文献
Activity of cabozantinib (XL184) in metastatic melanoma: Results from a phase II randomized discontinuation trial (RDT).
卡博替尼 (XL184) 在转移性黑色素瘤中的活性:II 期随机停药试验 (RDT) 的结果。
- DOI:
10.1200/jco.2012.30.15_suppl.8531 - 发表时间:
2012 - 期刊:
- 影响因子:45.3
- 作者:
Michael S. Gordon;Harriet M. Kluger;G. Shapiro;R. Kurzrock;G. Edelman;Thomas A. Samuel;A. Moussa;D. Ramies;A. D. Laird;F. Schimmoller;Xiao;A. Daud - 通讯作者:
A. Daud
Clonal determinants of organotropism and survival in metastatic uveal melanoma
转移性葡萄膜黑色素瘤器官趋向性和生存的克隆决定因素
- DOI:
10.1101/2024.05.14.593919 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Bailey S.C.L. Jones;Patrick C. Demkowicz;Mitchelle Matesva;Renelle Pointdujour Lim;John H. Sinard;Antonietta Bacchiocchi;Ruth Halaban;M. Bosenberg;Mario Sznol;Harriet M. Kluger;Mathieu F. Bakhoum - 通讯作者:
Mathieu F. Bakhoum
Harriet M. Kluger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Harriet M. Kluger', 18)}}的其他基金
Dual-isotope SPECT imaging and immunophenotyping of immune cells to determine response to immunotherapy
双同位素 SPECT 成像和免疫细胞免疫表型分析以确定对免疫治疗的反应
- 批准号:
10590408 - 财政年份:2023
- 资助金额:
$ 7.98万 - 项目类别:
The Yale Cancer Center Calabresi Immuno-Oncology Training Program (IOTP)
耶鲁大学癌症中心卡拉布雷西免疫肿瘤学培训计划 (IOTP)
- 批准号:
9899739 - 财政年份:2018
- 资助金额:
$ 7.98万 - 项目类别:
YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM
耶鲁大学癌症中心卡拉布雷西免疫肿瘤学培训计划
- 批准号:
10646793 - 财政年份:2018
- 资助金额:
$ 7.98万 - 项目类别:
A research and training program for junior clinicians in treating metastatic mela
初级临床医生治疗转移性黄斑变性的研究和培训计划
- 批准号:
8581535 - 财政年份:2013
- 资助金额:
$ 7.98万 - 项目类别:
A research and training program for junior clinicians in treating metastatic mela
初级临床医生治疗转移性黄斑变性的研究和培训计划
- 批准号:
8692684 - 财政年份:2013
- 资助金额:
$ 7.98万 - 项目类别:
A research and training program for junior clinicians in treating metastatic mela
初级临床医生治疗转移性黄斑变性的研究和培训计划
- 批准号:
9279067 - 财政年份:2013
- 资助金额:
$ 7.98万 - 项目类别:
Models to Predict Prognosis and Benefit from Adjuvant Therapy in Renal Cell Carci
预测肾细胞癌预后和辅助治疗获益的模型
- 批准号:
8613470 - 财政年份:2011
- 资助金额:
$ 7.98万 - 项目类别:
Models to predict prognosis and benefit from adjuvant therapy in renal cell carci
预测肾细胞癌预后和辅助治疗获益的模型
- 批准号:
8085276 - 财政年份:2011
- 资助金额:
$ 7.98万 - 项目类别:
Models to predict prognosis and benefit from adjuvant therapy in renal cell carci
预测肾细胞癌预后和辅助治疗获益的模型
- 批准号:
8236884 - 财政年份:2011
- 资助金额:
$ 7.98万 - 项目类别:
Models to predict prognosis and benefit from adjuvant therapy in renal cell carci
预测肾细胞癌预后和辅助治疗获益的模型
- 批准号:
8444714 - 财政年份:2011
- 资助金额:
$ 7.98万 - 项目类别:
相似国自然基金
面向一站式预约的门诊患者多检查动态调度优化研究
- 批准号:72371200
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
面向公平性的限行兼预约机制建模、分析与优化
- 批准号:72371010
- 批准年份:2023
- 资助金额:40.00 万元
- 项目类别:面上项目
面向集卡预约环境的港口集疏运道路作业计划与管控方法
- 批准号:52372303
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
考虑乘客消单行为的网约车拼车即时和预约订单联合派送优化研究
- 批准号:52302392
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
考虑医患自适应行为的医生门诊序列预约调度优化
- 批准号:72301058
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
HealthyU-Latinx: A Technology-based Tool for addressing Health Literacy in Latinx Secondary Students and their Families
HealthyU-Latinx:一种基于技术的工具,用于提高拉丁裔中学生及其家庭的健康素养
- 批准号:
10699830 - 财政年份:2023
- 资助金额:
$ 7.98万 - 项目类别:
Mitigating the Impact of Stigma and Shame as a Barrier to Viral Suppression Among MSM Living with HIV and Substance Use Disorders
减轻耻辱感和羞耻感对感染艾滋病毒和药物滥用的 MSM 的病毒抑制造成的影响
- 批准号:
10683694 - 财政年份:2023
- 资助金额:
$ 7.98万 - 项目类别:
Modification and Pilot Testing of The Capacity cOaching And exerCise after Hospitalization for Heart Failure (COACH-HF) Intervention
心力衰竭住院后能力训练和锻炼(COACH-HF)干预措施的修改和试点测试
- 批准号:
10539371 - 财政年份:2023
- 资助金额:
$ 7.98万 - 项目类别:
A Novel Algorithm to Identify People with Undiagnosed Alzheimer's Disease and Related Dementias
一种识别未确诊阿尔茨海默病和相关痴呆症患者的新算法
- 批准号:
10696912 - 财政年份:2023
- 资助金额:
$ 7.98万 - 项目类别: